52. When conducting a DEA-required inventory, an exact count is required for which of the following medications?
Answer: C
An exact count is required for Methylphenidate (Ritalin) during a DEA-required inventory.
Methylphenidate (Ritalin) is classified as a Schedule II controlled substance, which mandates an exact count during DEA-required inventories. This regulation ensures proper tracking and accountability of substances that have a high potential for abuse.
A) Zolpidem (Ambien)
Zolpidem is classified as a Schedule IV controlled substance. For medications in this category, an estimated count is permissible, making this option incorrect for the requirement of an exact count during a DEA inventory.
B) Acetaminophen with codeine (Tylenol #3)
Acetaminophen with codeine is classified as a Schedule III controlled substance. Similar to Schedule IV substances, an estimated count is acceptable, thus this option does not fulfill the requirement for an exact count.
C) Methylphenidate (Ritalin)
Methylphenidate is classified as a Schedule II controlled substance, which requires an exact count during DEA-required inventories. This classification reflects the high potential for abuse associated with this medication, making it essential to maintain strict inventory controls.
D) Alprazolam (Xanax)
Alprazolam is a Schedule IV controlled substance, which allows for an estimated count during inventory. This does not meet the criteria for requiring an exact count, rendering this option incorrect.
Conclusion
Methylphenidate (Ritalin) is the only medication listed that requires an exact count during a DEA-required inventory due to its classification as a Schedule II controlled substance. All other options, being classified as Schedule III or IV, allow for estimated counts, making them unsuitable for this specific requirement.